seca news.

Actualités de l'entreprise.

Expansion course in BeNeLux: seca conquers next fitness market

- At the end of a successful year, the signs are pointing to expansion at seca: the specialist for medically validated bioimpedance measuring devices for determining body composition is entering the up-and-coming fitness market in the BeNeLux countries.


Log4j security vulnerability - seca products are not affected.

- In connection with the latest findings about Log4J vulnerabilities, seca has conducted extensive analyses to ensure the security of our devices and thus the (data) security of our customers. The open source tool called Log4J is not used in any of our products. This means that none of our products are affected by the security vulnerabilities. In the development of our products we attach great importance to the highest security standards and will do our utmost to maintain them in the future, so that our partners can rely on us. If you have any further questions, please contact info@seca.com.


COVID-19 : Les paramètres de base tels que le poids, la taille et les données vitales ne doivent pas être oubliés, en particulier dans le cas de groupes à risque

- La pandémie de COVID-19 pose des défis majeurs aux médecins et aux systèmes de santé du monde entier. Les personnes souffrant de pathologies préexistantes présentent un risque accru de connaître une évolution sévère de l’infection. Des publications de revues médicales spécialisées et d’organismes indépendants soulignent le rôle essentiel d’une mesure précise des paramètres vitaux dans le traitement des groupes à risque atteints de la COVID-19. La taille, le poids et les données vitales telles que la pression artérielle, le taux de saturation en oxygène, le pouls et la température, sont importants pour le dosage précis des médicaments et le réglage des appareils respiratoires. De plus, ces…


seca augmente ses capacités de production dédiées à la technologie médicale indispensable à la garantie du système de santé.

L’approvisionnement des hôpitaux, des cliniques, des urgences et des cabinets médicaux est une priorité absolue.

- dans beaucoup de pays, les autorités et les institutions responsables ont classé seca, leader mondial sur le marché des balances médicales et des systèmes de mesure, comme soutien aux fonctions essentielles du système de santé dans la lutte contre la pandémie du COVID-19. Etant donné la situation actuelle, la pression dans les urgences et les hôpitaux est extrêmement élevée et le besoin en produits de technique médicale a considérablement augmenté. Afin d’assurer au mieux ces besoins, seca maintient sa production et accroît même ses capacités pour contribuer à la lutte contre le Coronavirus.


A strong partner – in the time of Covid-19 too

We stand by you

- While the whole world is attempting to slow down the number of new infections with coronavirus, we are concentrating on protecting our employees and instituting measures to make sure our production in Hamburg remains fully operational. Our production site in Hangzhou has returned to 90 percent of production capacity since China ended its shutdown. That gives us hope and sends a positive signal to everyone. We take this opportunity to thank all our employees and partners whose support and engagement are keeping our products and service available to all who need them.


seca is awarded MDR certification

EU Medical Device Regulation successfully implemented three months before it fully comes into force

- As one of the first Med Tech companies in Europe, seca is the global market leader in medical measuring and weighing and has passed the official MDR (Medical Device Regulation) audit even before the new EU regulation comes into effect in May 2020. Three auditors from the Notified Body (TÜV-SÜD Product Service) analyzed and audited the seca quality management system in accordance with the MDR requirements for medical devices and assessed all of them as successfully met.


Global medical societies define reduced muscle mass as an independent criterion for diagnosis of malnutrition

Validated BIA from seca conforms to consensus on diagnostic methods

- The international societies ASPEN, ESPEN, FELANPE and PENSA established the Global Leadership Initiative in Malnutrition (GLIM) to build a worldwide consensus for diagnostic criteria for malnutrition. The consensus report published in September 2018 elevates reduced muscle mass to one of the decisive, independent evaluation criteria used in the diagnosis of malnutrition. seca welcomes this step, which the company sees as validation of its advocacy of improved diagnosis and treatment of malnutrition.


16th international branch: seca opens Benelux office

German medical technology company to build on successful projects in viable Benelux markets

- Right on the heels of the November opening of the seca | lietuva site, the market leader in medical measuring systems and scales has opened its 16th international subsidiary seca | benelux. The company sees great potential in the progressive healthcare sector in Benelux countries and opportunities for sales, particularly of its EMR-ready and digital measuring solutions.